Previous close | 2.4799 |
Open | 2.5050 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.5000 - 2.5050 |
52-week range | 2.5000 - 2.5050 |
Volume | |
Avg. volume | N/A |
Market cap | 2.281M |
Beta (5Y monthly) | 1.80 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.0560 |
Earnings date | 22 Feb 2023 - 27 Feb 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The popular growth investor publishes her daily transactions. She keeps buying Tesla as well as some low-priced genetics specialists.
Three stocks that fit that criteria and while still generating positive growth numbers include Invitae (NYSE: NVTA), Salesforce (NYSE: CRM), and Tesla (NASDAQ: TSLA). Should you buy these three growth stocks right now, or are tougher times ahead for their businesses? Diagnostics company Invitae has plenty of long-term promise.
The bears have prevailed with Invitae this year. But could the future be better for the beaten-down stock?